According to recent research, there is evidence of a rise in the DNA methylation level of the XPO4 promoter in peripheral blood mononuclear cells (PBMCs) when chronic hepatitis B progresses to cirrhosis and hepatocellular carcinoma (HCC) [8]. The gene discussed is XPO4; the disease is hepatocellular carcinoma.